The first reported case and management of multicentric Castleman's disease associated with Kaposi's sarcoma in an HIV-2-infected patient [2]

AIDS

Volumn 21, Issue 11, 2007, Pages 1492-1494

  Sophie, Bouvresse ^a   Anne Geneviève, Marcelin ^b   Nathalie, Franck ^a   Stéphanie, Regnier ^a   Florence, Damond ^c   Micheline, Tulliez ^a   Nicolas, Dupin ^a  

^a Tarnier Cochin Hospital ^*  (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; GANCICLOVIR; LOPINAVIR; RITONAVIR; RITUXIMAB; TENOFOVIR; VINBLASTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANOREXIA; ASTHENIA; BIOPSY; BLOODY DIARRHEA; CASE REPORT; COLON BIOPSY; DRUG WITHDRAWAL; HEPATOMEGALY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN TISSUE; KAPOSI SARCOMA; LETTER; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HIV-2; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; SARCOMA, KAPOSI;

EID: 34250821209     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3281df33fc     Document Type: Letter

References (10)

1. Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, et al. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996; 10:61-67.
2. Lachant NA, Sun NC, Leong LA, Oseas RS, Prince HE. Multi-centric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 1985; 83:27-33.
3. Ariyoshi K, Schim van der Loeff M, Cook P, Whitby D, Corrah T, Jaffar S, et al. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1:193-199.
4. Gallo RC. HIV-1, HHV-8, and Kaposi's sarcoma. J Hum Virol 1998; 1:185-186.
5. Dupin N, Krivine A, Calvez V, Gorin I, Franck N, Escande JP. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient. AIDS 1997; 11:1400-1401.
6. Zietz C, Bogner JR, Goebel FD, Lohrs U. An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS. N Engl J Med 1999; 340:1923-1924.
7. Casper C, Nichols WG, Huang ML, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 2004; 103:1632-1634.
8. Berezne A, Agbalika F, Oksenhendler E. Failure of cidofovir in HIV-associated multicentric Castleman disease. Blood 2004; 103:4368-4369.
9. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, et al. Long-term remission of Kaposi sarcomaassociated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 2001; 98:3473-3475.
10. Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, et al. Rituximab therapy for HIV-associated Castleman disease. Blood 2003; 102:2786-2788.